Literature DB >> 31570380

Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis.

Toni Celià-Terrassa1, Mohit Kumar Jolly2.   

Abstract

The cancer stem cell (CSC) concept stands for undifferentiated tumor cells with the ability to initiate heterogeneous tumors. It is also relevant in metastasis and can explain how metastatic tumors mirror the heterogeneity of primary tumors. Cellular plasticity, including the epithelial-to-mesenchymal transition (EMT), enables the generation of CSCs at different steps of the metastatic process including metastatic colonization. In this review, we update the concept of CSCs and provide evidence of the existence of metastatic stem cells (MetSCs). In addition, we highlight the nuanced understanding of EMT that has been gained recently and the association of mesenchymal-to-epithelial transition (MET) with the acquisition of CSCs properties during metastasis. We also comment on the computational approaches that have profoundly influenced our understanding of CSCs and EMT; and how these studies and new experimental technologies can yield a deeper understanding of the biological aspects of metastasis.
Copyright © 2020 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 31570380      PMCID: PMC7328448          DOI: 10.1101/cshperspect.a036905

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   5.159


  155 in total

1.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

Authors:  Oscar H Ocaña; Rebeca Córcoles; Angels Fabra; Gema Moreno-Bueno; Hervé Acloque; Sonia Vega; Alejandro Barrallo-Gimeno; Amparo Cano; M Angela Nieto
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

2.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

3.  Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity.

Authors:  Robert Strauss; Zong-Yi Li; Ying Liu; Ines Beyer; Jonas Persson; Pavel Sova; Thomas Möller; Sari Pesonen; Akseli Hemminki; Petra Hamerlik; Charles Drescher; Nicole Urban; Jiri Bartek; André Lieber
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

4.  Single-cell dissection of transcriptional heterogeneity in human colon tumors.

Authors:  Piero Dalerba; Tomer Kalisky; Debashis Sahoo; Pradeep S Rajendran; Michael E Rothenberg; Anne A Leyrat; Sopheak Sim; Jennifer Okamoto; Darius M Johnston; Dalong Qian; Maider Zabala; Janet Bueno; Norma F Neff; Jianbin Wang; Andrew A Shelton; Brendan Visser; Shigeo Hisamori; Yohei Shimono; Marc van de Wetering; Hans Clevers; Michael F Clarke; Stephen R Quake
Journal:  Nat Biotechnol       Date:  2011-11-13       Impact factor: 54.908

Review 5.  The epithelial-mesenchymal transition: new insights in signaling, development, and disease.

Authors:  Jonathan M Lee; Shoukat Dedhar; Raghu Kalluri; Erik W Thompson
Journal:  J Cell Biol       Date:  2006-03-27       Impact factor: 10.539

6.  A microfluidic device for label-free, physical capture of circulating tumor cell clusters.

Authors:  A Fatih Sarioglu; Nicola Aceto; Nikola Kojic; Maria C Donaldson; Mahnaz Zeinali; Bashar Hamza; Amanda Engstrom; Huili Zhu; Tilak K Sundaresan; David T Miyamoto; Xi Luo; Aditya Bardia; Ben S Wittner; Sridhar Ramaswamy; Toshi Shioda; David T Ting; Shannon L Stott; Ravi Kapur; Shyamala Maheswaran; Daniel A Haber; Mehmet Toner
Journal:  Nat Methods       Date:  2015-05-18       Impact factor: 28.547

Review 7.  Phenotypic Plasticity and Cell Fate Decisions in Cancer: Insights from Dynamical Systems Theory.

Authors:  Dongya Jia; Mohit Kumar Jolly; Prakash Kulkarni; Herbert Levine
Journal:  Cancers (Basel)       Date:  2017-06-22       Impact factor: 6.639

8.  Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

Authors:  Nicola Aceto; Aditya Bardia; David T Miyamoto; Maria C Donaldson; Ben S Wittner; Joel A Spencer; Min Yu; Adam Pely; Amanda Engstrom; Huili Zhu; Brian W Brannigan; Ravi Kapur; Shannon L Stott; Toshi Shioda; Sridhar Ramaswamy; David T Ting; Charles P Lin; Mehmet Toner; Daniel A Haber; Shyamala Maheswaran
Journal:  Cell       Date:  2014-08-28       Impact factor: 41.582

9.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

10.  Efficient tumour formation by single human melanoma cells.

Authors:  Elsa Quintana; Mark Shackleton; Michael S Sabel; Douglas R Fullen; Timothy M Johnson; Sean J Morrison
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962

View more
  29 in total

Review 1.  Interconnected high-dimensional landscapes of epithelial-mesenchymal plasticity and stemness in cancer.

Authors:  Sarthak Sahoo; Bazella Ashraf; Atchuta Srinivas Duddu; Adrian Biddle; Mohit Kumar Jolly
Journal:  Clin Exp Metastasis       Date:  2022-01-07       Impact factor: 5.150

2.  Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling.

Authors:  Xiangzhou Chen; Mingqiang Yang; Jiang Yin; Pan Li; Shanshan Zeng; Guopei Zheng; Zhimin He; Hao Liu; Qian Wang; Fan Zhang; Danyang Chen
Journal:  Cell Commun Signal       Date:  2022-06-17       Impact factor: 7.525

3.  Mortalin maintains breast cancer stem cells stemness via activation of Wnt/GSK3β/β-catenin signaling pathway.

Authors:  Bo Wei; Jia Cao; Jin-Hai Tian; Chuan-Yang Yu; Qi Huang; Jing-Jing Yu; Rong Ma; Jia Wang; Fang Xu; Li-Bin Wang
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

Review 4.  Reporters of Cancer Stem Cells as a Tool for Drug Discovery.

Authors:  Amrutha Mohan; Reshma Raj R; Gayathri Mohan; Padmaja K P; Tessy Thomas Maliekal
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

5.  PKCα Inhibition as a Strategy to Sensitize Neuroblastoma Stem Cells to Etoposide by Stimulating Ferroptosis.

Authors:  Lorenzo Monteleone; Andrea Speciale; Giulia Elda Valenti; Nicola Traverso; Silvia Ravera; Ombretta Garbarino; Riccardo Leardi; Emanuele Farinini; Antonella Roveri; Fulvio Ursini; Claudia Cantoni; Maria Adelaide Pronzato; Umberto Maria Marinari; Barbara Marengo; Cinzia Domenicotti
Journal:  Antioxidants (Basel)       Date:  2021-04-28

Review 6.  Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response.

Authors:  Michelle von Locquenghien; Catalina Rozalén; Toni Celià-Terrassa
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

7.  Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study.

Authors:  Lu Cao; Prashanth Prithviraj; Ritu Shrestha; Revati Sharma; Matthew Anaka; Kim R Bridle; George Kannourakis; Darrell H G Crawford; Aparna Jayachandran
Journal:  J Clin Med       Date:  2021-05-19       Impact factor: 4.241

8.  Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma.

Authors:  Yongrong Lei; Xishu Wang; Heng Sun; Yuna Fu; Yichen Tian; Ludi Yang; Jianhua Wang; Feng Xia
Journal:  Front Oncol       Date:  2021-05-27       Impact factor: 6.244

Review 9.  Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment.

Authors:  Anamarija Habič; Metka Novak; Bernarda Majc; Tamara Lah Turnšek; Barbara Breznik
Journal:  J Histochem Cytochem       Date:  2021-07-26       Impact factor: 2.479

Review 10.  Markers and Reporters to Reveal the Hierarchy in Heterogeneous Cancer Stem Cells.

Authors:  Amrutha Mohan; Reshma Raj Rajan; Gayathri Mohan; Padmaja Kollenchery Puthenveettil; Tessy Thomas Maliekal
Journal:  Front Cell Dev Biol       Date:  2021-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.